BRAINXPLORE

Check out our news

Get our newsletters

Published on the 31 March 2016

Immunization therapies, synuclein and Parkinson’s disease – multiple system atrophy

Vaccination is increasingly being investigated as a potential treatment for synucleinopathies, a group of neurodegenerative diseases including Parkinson's disease, multiple system atrophy, and dementi…

Science and innovation
Published on the 22 March 2016

Synucleopathies and preclinical Parkinson disease models

Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies, have all something in common. They all belong to a group of neurodegenerative diseases called synucleinopathies, including p…

Science and innovation
Published on the 16 March 2016

Neuroprotective effects of Omega-3 on 6 OHDA Parkinson preclinical mice.

Researchers from the CHU Research centre in Quebec have shown that diet can play a neuroprotective role in a preclinical Parkinson mouse model. They investigated the effects of a omega-3 polyunsaturat…

Science and innovation
Published on the 2 February 2016

Syncrosome Poster 6 OHDA Parkinson and dyskinesia

This poster has been presented at the last 2015 World Parkinson Congress in France, and shows interesting results concerning an antidyskinetic compound in a rat 6 OHDA Parkinson model. Dyskinesias are…

Science and innovation Events
Published on the 25 January 2016

Immunization therapies, synuclein and Parkinson’s disease – multiple system atrophy

Vaccination is increasingly being investigated as a potential treatment for synucleinopathies, a group of neurodegenerative diseases including Parkinson's disease (synuclein Parkinson), multiple syste…

Science and innovation
Published on the 25 January 2016

Neurorescue and DHA on a 6OHDA preclinical Parkinson model

Preclinical data collected in models of preclinical Parkinson disease (PD) support the neuroprotective potential of omega-3 polyunsaturated fatty acids (n-3 PUFA)-enriched diet on the dopaminergic (D…

Science and innovation
Published on the 26 November 2015

Alpha-synuclein in Parkinson disease

Alpha Synuclein Parkinson: Formation and accumulation of misfolded protein aggregates are a central hallmark of several neurodegenerative diseases. In Parkinson’s disease (PD), the aggregation-prone p…

Science and innovation
Published on the 6 December 2013

ETAP will be present at the 20th world congress on Parkinson’s disease and related disorders – represented by C. MULLER

You can meet C. MULLER to talk about the activities of ETAP and Neurodegenerative diseases models. For more information about this congress click here.

Events

Discover our scientific resources and browse posters…

Discover our resources